Peer Review History

Original SubmissionMay 9, 2022
Decision Letter - Renato Polimanti, Editor

PONE-D-22-13525Causal relationships between sex hormone traits, lifestyle factors, and osteoporosis in men: A Mendelian randomization studyPLOS ONE

Dear Dr. zhao,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

 To be considered for publication, the authors should fully address the comments received.

Please submit your revised manuscript by Jul 21 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Renato Polimanti, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: https://www.youtube.com/watch?v=_xcclfuvtxQ

Additional Editor Comments:

Wang and colleagues conducted an interesting Mendelian randomization analysis to test the effect linking sex hormones, lifestyle factors, and osteoporosis in men. Although the analyses are generally adequate. There are major issues that the authors should address:

1. The authors should clarify whether there is sample overlap among the datasets investigated because this could introduce a bias in the analyses performed.

2. The authors performed a less stringent clumping than that usually applied in the MR field (see PMID: 31448343). They should clarify why they made this decision and whether this may have confounded the results of the analyses conducted.

3. The authors reported GSCAN sample sizes as including 23andMe data. 23andMe data are not publicly available. The authors should clarify whether they obtained these data. If 23andMe were not obtained, they should report the correct sample size.

4. It would be important to perform a multivariable MR to verify the independence of the effects identified.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Causal relationships between sex hormone traits, lifestyle factors, and osteoporosis in men: A Mendelian randomization study

This study assessed the potential causal relationship of osteoporosis in men with sex hormones and lifestyle-related factors. The subject of this study is interesting and important. Based on the methods described, I am satisfied that the study was appropriately designed and conducted. I have only minor comments for author’s consideration in improving the presentation of this study.

First, it is not clear what informed the choice of the lifestyle factors assessed in this study. This is important given there are many similar factors that have been associated with the outcome of interest. How did author trim down the ‘lifestyle’ factors to arrive at the one assessed here, or was it just a random selection? Further, I would not call BMI a lifestyle factor.

Second, lines 65 – 66: ‘However, the true causal relationships between these risk factors and osteoporosis have not been fully established.’ The use of ‘true’ here may send a different message, especially as MR cannot be said to be able to assess ‘true’ causal effect. The question that can arise would be has there been any assessment of the causal relationship between these factors and osteoporosis (in men in particular). If yes, state it and highlight the gap the present study fills. If not, then I suggest authors should remove ‘true’ as this can be controversial.

Third, lines 106 – 107: ‘Therefore, BMD statistics were used to represent osteoporosis in our MR analysis.’ To what extent does the BMD represent osteoporosis? Any reference to support this?

Fourth, the presentation/description of the results can be difficult to follow, understandably because of the many factors, and MR models. I see the Tables and Figures are much clearer, especially, Table S1. Can authors follow a similar approach in describing their results and provide a sub-section for each of the exposure variables (as in Table S1). This will enhance the clarity of this work and enable readers to comprehend the findings. The same applies to the discussion section, authors can use a similar approach without the need for sub-sections.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Dr Emmanuel Adewuyi

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

Replies to the reviewers’ comments:

Reviewer #1: Additional Editor Comments

1. The authors should clarify whether there is sample overlap among the datasets investigated because this could introduce a bias in the analyses performed.

Response:The analysis data for exposure in this study were from UK Biobank and published papers, and the outcome data were from published papers, excluding UK Biobank , so the overlap between exposure and outcome was avoided. We added an explanation in the article, on lines 114-116.

2. The authors performed a less stringent clumping than that usually applied in the MR field (see PMID: 31448343). They should clarify why they made this decision and whether this may have confounded the results of the analyses conducted.

Response:An important step in MR studies is to remove SNPS with linkage disequilibrium(LD). The LD is mainly using two parameters, r2 and KB. R2 is the data between 0 and 1. R2 =1 indicates that there is a complete LD between two SNPS. R2 =0 indicates that there is a complete linkage equilibrium between two SNPS. KB is the length of the region of linkage imbalance. With the decrease of R2 and the increase of KB, more and more SNPs with LD will be removed, and less and less IV will be left. Generally, the less the number of IV is, the less promiscuous and pluripotency exists, but the corresponding statistical power may be insufficient. The most common default parameters in literature are (r2=0.001, kb=10000) and (r2=0.01, kb=5000). Parameter (r2=0.01, kb=5000) is set moderately, and this parameter is also used in some published articles, such as PMID: 35267896 and PMID: 35140703. It is believed that this parameter setting will not confound the analysis results.

3. The authors reported GSCAN sample sizes as including 23andMe data. 23andMe data are not publicly available. The authors should clarify whether they obtained these data. If 23andMe were not obtained, they should report the correct sample size.

Response:IVs associated with smoking and alcohol status were identified in this study from the GSCAN Consortium. The data obtained by us comes from the article PMID: 30643251 (https://doi.org/10.1038/s41588-018-0307-5), in which sample size is introduced and relevant SNPs information can be obtained in the attached table. In addition, we have attached a new excel table (file S1) for all SNPs characteristics as Ivs in exposure. Line130-131.

4. It would be important to perform a multivariable MR to verify the independence of the effects identified.

Response:In this study, different factors were used to explore the causal relationship between BMD at four sites. Multiple factors were found only in the HE-BMD as the outcome, so the multivariable analysis in this section has been added in accordance with the editor's comments (lines 225-237). Some changes have also been made to lines 249-250 and 300 in the discussion section.

Reviewer #2: Review Comments

1. First, it is not clear what informed the choice of the lifestyle factors assessed in this study. This is important given there are many similar factors that have been associated with the outcome of interest. How did author trim down the ‘lifestyle’ factors to arrive at the one assessed here, or was it just a random selection? Further, I would not call BMI a lifestyle factor.

Response:Indeed, there may be many lifestyle factors. In this paper, we want to explore the three most common factors: smoking, drinking and diet. In view of the fact that the body shape is the most relevant to the amount of food consumed, BMI was included into the lifestyle factors in this study. The corresponding explanatory text is added to lines 92-94 of the article.

2. Second, lines 65 – 66: ‘However, the true causal relationships between these risk factors and osteoporosis have not been fully established.’ The use of ‘true’ here may send a different message, especially as MR cannot be said to be able to assess ‘true’ causal effect. The question that can arise would be has there been any assessment of the causal relationship between these factors and osteoporosis (in men in particular). If yes, state it and highlight the gap the present study fills. If not, then I suggest authors should remove ‘true’ as this can be controversial.

Response: The reviewer's suggestion was very accurate, and we have deleted the "true" (line 65) according to the reviewer's suggestion.

3. Third, lines 106 – 107: ‘Therefore, BMD statistics were used to represent osteoporosis in our MR analysis.’ To what extent does the BMD represent osteoporosis? Any reference to support this?

Response: Osteoporosis is characterized by reduced bone density and an increased risk of fracture. Bone mineral density (BMD), which represents bone strength, is often used in the clinical diagnosis of osteoporosis[14,15]. In several Mendelian randomized analyses of osteoporosis, BMD was also used instead of osteoporosis. References are: PMID: 34105796; PMID: 35646051; PMID: 33439309; PMID: 34259888.

4. Fourth, the presentation/description of the results can be difficult to follow, understandably because of the many factors, and MR models. I see the Tables and Figures are much clearer, especially, Table S1. Can authors follow a similar approach in describing their results and provide a sub-section for each of the exposure variables (as in Table S1). This will enhance the clarity of this work and enable readers to comprehend the findings. The same applies to the discussion section, authors can use a similar approach without the need for sub-sections.

Response: Table S1 has summarized the results of 7 exposure factors corresponding to BMD at 4 different sites used as outcome. For each of the exposure variables, a new excel table (file S1) is attached to show the characteristics of each SNP because there are a large number of SNPs selected as being closely related to 7 exposures. Line 130-131

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - Renato Polimanti, Editor

Causal relationships between sex hormone traits, lifestyle factors, and osteoporosis in men: A Mendelian randomization study

PONE-D-22-13525R1

Dear Dr. zhao,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Renato Polimanti, Ph.D.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

The authors adequately addressed the main comments made by reviewers and no further changes are needed.

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Author has largely addressed all my comments.

It appears, though, from authors' response, that my comment no 4 did not come across clearly. What I requested was for author to describe their results (in the results section) according to the main headings, possibly using subsections. This will enhance clarity of the study. However, if this is not possible, I think, I am satisfied overall. The Tables and Figures are helpful.

Just a few minor comments as follows:

1. While I note that Table 1 clarified whether the GWAS was for male or female, this detail needs to be clearly stated in the methods section as well. Can author state this information for each of the GWAS in the relevant section of the methods.

2. Also, author need to state the limitation(s) of including female GWASs (for Smoking and drinking) since this study is focused on men (male).

3. Lastly, authors need to read over their conclusion both in the abstract and the main manuscript. I expect a concise take home message from this study, especially, in line with the argument of the authors regarding the importance of the study.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Dr Emmanuel Adewuyi

**********

Formally Accepted
Acceptance Letter - Renato Polimanti, Editor

PONE-D-22-13525R1

Causal relationships between sex hormone traits, lifestyle factors, and osteoporosis in men: A Mendelian randomization study

Dear Dr. Zhao:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Renato Polimanti

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .